Rapid Normalization of Vitamin D Deficiency in PICU

PHASE3CompletedINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

October 17, 2024

Study Completion Date

October 17, 2024

Conditions
Vitamin D Deficiency
Interventions
DRUG

Cholecalciferol

Single enteral cholecalciferol load at a dose of 10,000 IU/kg (maximum 400,000 IU)

OTHER

Placebo

Single enteral placebo dose equivalent in volume to the appropriate weight-based dose of cholecalciferol

Trial Locations (10)

T3B 6A8

Alberta Children's Hospital, Calgary

T5J 3E4

Stollery Children's Hospital, Edmonton

V6H 3V4

BC Children's Hospital, Vancouver

B3K 6R8

IWK Health Centre, Halifax

L8N 3Z5

McMaster Children's Hospital, Hamilton

N6C 3T6

Division of Critical Care, Department of Pediatrics, Victoria Hospital, London

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

M5G 1X8

The Hospital for Sick Children, Toronto

H3T 1C5

Centre hospitalier universitaire Sainte-Justine, Montreal

H4A 3J1

Montreal Children's Hospital, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

EURO-PHARM International Canada, Inc.

OTHER

collaborator

Canadian Critical Care Trials Group

OTHER

lead

Children's Hospital of Eastern Ontario

OTHER

NCT03742505 - Rapid Normalization of Vitamin D Deficiency in PICU | Biotech Hunter | Biotech Hunter